Skip to main content
. 2023 Apr 15;14(4):396–411. doi: 10.4239/wjd.v14.i4.396

Figure 2.

Figure 2

The mechanisms of actions of glucagon-like insulinotropic peptide-1 agonists in improving diabesity.